ALS News Today

Check out this article from ALS News Today on Retrotope’s rapid enrollment of its ongoing Phase 2 trial of RT001 for the treatment of amyotrophic lateral sclerosis (ALS). The piece offers great context on the ongoing study, as well as how the mechanism of action for RT001 may be able to help patients with neurodegenerative diseases such as ALS.

https://alsnewstoday.com/news-posts/2021/05/07/retrotope-phase-2-trial-rt001-fully-enrolled-als/